ENDONOVO THERAPEUTICS, INC. Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • Endonovo Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2023 was -409 %, a 123% decline year-over-year.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2022 was -1.2K %, a 766% decline from 2021.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2021 was -139 %, a 892% decline from 2020.
  • Endonovo Therapeutics, Inc. annual Return On Assets for 2020 was -14 %, a 97.1% increase from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -1.2K -1.06K -766% Jan 1, 2022 Dec 31, 2022
2021 -139 -125 -892% Jan 1, 2021 Dec 31, 2021
2020 -14 +461 +97.1% Jan 1, 2020 Dec 31, 2020
2019 -475 -330 -227% Jan 1, 2019 Dec 31, 2019
2018 -145 +665 +82.1% Jan 1, 2018 Dec 31, 2018
2017 -811 +1.41K +63.4% Jan 1, 2017 Dec 31, 2017
2016 -2.22K +2.38K +51.7% Jan 1, 2016 Dec 31, 2016
2015 -4.59K Jan 1, 2015 Dec 31, 2015
2013 -3.64K -3.39K -1356% Jan 1, 2013 Dec 31, 2013
2012 -250 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.